| Multi-system neurological disease is common in patients with OPA1 mutations P Yu-Wai-Man, PG Griffiths, GS Gorman, CM Lourenco, AF Wright, ... Brain 133 (3), 771-786, 2010 | 455 | 2010 |
| Familial cerebellar ataxia with muscle coenzyme Q10 deficiency O Musumeci, A Naini, AE Slonim, N Skavin, GL Hadjigeorgiou, ... Neurology 56 (7), 849-855, 2001 | 322 | 2001 |
| Phenotypic heterogeneity of the 8344A> G mtDNA “MERRF” mutation M Mancuso, D Orsucci, C Angelini, E Bertini, V Carelli, GP Comi, C Minetti, ... Neurology 80 (22), 2049-2054, 2013 | 213 | 2013 |
| Pharmacological inhibition of necroptosis protects from dopaminergic neuronal cell death in Parkinson’s disease models A Iannielli, S Bido, L Folladori, A Segnali, C Cancellieri, A Maresca, ... Cell reports 22 (8), 2066-2079, 2018 | 203 | 2018 |
| Syndromic parkinsonism and dementia associated with OPA1 missense mutations V Carelli, O Musumeci, L Caporali, C Zanna, C La Morgia, V Del Dotto, ... Annals of neurology 78 (1), 21-38, 2015 | 188 | 2015 |
| Coenzyme Q–responsive Leigh's encephalopathy in two sisters L Van Maldergem, F Trijbels, S DiMauro, PJ Sindelar, O Musumeci, ... Annals of Neurology: Official Journal of the American Neurological …, 2002 | 171 | 2002 |
| Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 years C Angelini, C Semplicini, S Ravaglia, B Bembi, S Servidei, E Pegoraro, ... Journal of neurology 259, 952-958, 2012 | 161 | 2012 |
| The m. 3243A> G mitochondrial DNA mutation and related phenotypes. A matter of gender? M Mancuso, D Orsucci, C Angelini, E Bertini, V Carelli, GP Comi, A Donati, ... Journal of neurology 261, 504-510, 2014 | 158 | 2014 |
| Diagnosis of glycogenosis type II B Bembi, E Cerini, C Danesino, MA Donati, S Gasperini, L Morandi, ... Neurology 71 (23_suppl_2), S4-S11, 2008 | 145 | 2008 |
| Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial J Diaz-Manera, PS Kishnani, H Kushlaf, S Ladha, T Mozaffar, V Straub, ... The Lancet Neurology 20 (12), 1012-1026, 2021 | 119 | 2021 |
| Surprises of genetic engineering: a possible model of polyglucosan body disease N Raben, M Danon, N Lu, E Lee, L Shliselfeld, AV Skurat, PJ Roach, ... Neurology 56 (12), 1739-1745, 2001 | 119 | 2001 |
| The genetic basis of undiagnosed muscular dystrophies and myopathies: results from 504 patients M Savarese, G Di Fruscio, A Torella, C Fiorillo, F Magri, M Fanin, ... Neurology 87 (1), 71-76, 2016 | 115 | 2016 |
| The italian limb girdle muscular dystrophy registry: Relative frequency, clinical features, and differential diagnosis F Magri, V Nigro, C Angelini, T Mongini, M Mora, I Moroni, A Toscano, ... Muscle & nerve 55 (1), 55-68, 2017 | 111 | 2017 |
| Redefining phenotypes associated with mitochondrial DNA single deletion M Mancuso, D Orsucci, C Angelini, E Bertini, V Carelli, GP Comi, ... Journal of neurology 262, 1301-1309, 2015 | 106 | 2015 |
| MYH7-related myopathies: clinical, histopathological and imaging findings in a cohort of Italian patients C Fiorillo, G Astrea, M Savarese, D Cassandrini, G Brisca, F Trucco, ... Orphanet journal of rare diseases 11, 1-14, 2016 | 94 | 2016 |
| Safety and efficacy of cipaglucosidase alfa plus miglustat versus alglucosidase alfa plus placebo in late-onset Pompe disease (PROPEL): an international, randomised, double … B Schoser, M Roberts, BJ Byrne, S Sitaraman, H Jiang, P Laforêt, ... The Lancet Neurology 20 (12), 1027-1037, 2021 | 91 | 2021 |
| Management and treatment of glycogenosis type II B Bembi, E Cerini, C Danesino, MA Donati, S Gasperini, L Morandi, ... Neurology 71 (23_suppl_2), S12-S36, 2008 | 91 | 2008 |
| Multisystem late onset Pompe disease (LOPD): an update on clinical aspects A Toscano, C Rodolico, O Musumeci Annals of translational medicine 7 (13), 2019 | 90 | 2019 |
| Defective autophagy in spastizin mutated patients with hereditary spastic paraparesis type 15 C Vantaggiato, C Crimella, G Airoldi, R Polishchuk, S Bonato, E Brighina, ... Brain 136 (10), 3119-3139, 2013 | 87 | 2013 |
| LOPED study: looking for an early diagnosis in a late-onset Pompe disease high-risk population O Musumeci, G la Marca, M Spada, S Mondello, C Danesino, GP Comi, ... Journal of Neurology, Neurosurgery & Psychiatry 87 (1), 5-11, 2016 | 85 | 2016 |
